| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 13 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 12 |
| 2 | TACROLIMUS OINTMENT 0.1% | 12 |
| 3 | CYCLOPHOSPHAMIDE | 10 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 6 | MYCOPHENOLATE MOFETIL | 10 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 10 |
| 8 | INFLIXIMAB | 9 |
| 9 | PREDNISOLONE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AURANOFIN | 1 | 0.0049 |
| 1 | MEBENDAZOLE | 2 | 0.0025 |
| 2 | I. V. FAT EMULSION | 1 | 0.0014 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 4 | OLOPATADINE HYDROCHLORIDE OPHTHALMIC | 1 | 0.0002 |
| 5 | TRANEXAMIC ACID | 2 | 0.0002 |
| 6 | INSULIN DEGLUDEC | 5 | 0.0002 |
| 7 | OLOPATADINE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | APREPITANT | 1 | 0.0001 |
| 9 | TACROLIMUS OINTMENT 0.1% | 12 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 2 | 0.0007 |
| 1 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 2 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 10 | 0.0000 |
| 7 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 3 | 0.0000 |